New test predicts blood cancer’s sensitivity to experimental cancer drug
A test developed by Dana-Farber Cancer Institute scientists is the first to identify which malignant blood cells are highly vulnerable to a promising type of experimental drugs that unleash pent-up “cell suicide” factors to destroy the cancer.



Tina Radcliffe spent ten years as a Oncology Certified R.N. working with in-patients on oncology and med-surg units. She also has a background in home health and geriatrics. Her other experiences include ... .. 

































[...] (Read the rest of this article …) [...]
Comment by BATTLING FOR HEALTH: CANCER » Blog Archive » New test predicts blood cancer’s sensitivity to experimental cancer drug on September 19, 2007 8:02 pm